Skip to content
HowShorted

Semler Scientific, Inc. short interest in 2025

In 2025, Semler Scientific, Inc.'s disclosed short interest ran from 16.20% of shares outstanding on 15 Jan 2025 to 18.20% on 31 Dec 2025, a change of +2.00 percentage points. The year's high was 29.35% on 30 Jun 2025 and its low 14.05% on 31 Oct 2025, averaging 19.81% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 6.92 days on 15 Apr 2025. Full history: Semler Scientific, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2021 · 2022 · 2023 · 2024 · 2025

Aggregate net short position time series for Semler Scientific, Inc. in 2025

2025 in figures

Start of year
16.20% (15 Jan 2025)
End of year
18.20% (31 Dec 2025)
Change
+2.00 pp
High
29.35% (30 Jun 2025)
Low
14.05% (31 Oct 2025)
Average
19.81%
Highest days to cover
6.92 (15 Apr 2025)
SEC filings marked
12

Every report in 2025

Semler Scientific, Inc. short interest in 2025
SettlementShort interestDays to coverFilings since previous
15 Jan 202516.20%2.71
31 Jan 202524.65%3.36results (8-K)
14 Feb 202523.90%5.74
28 Feb 202517.11%3.96results (8-K), 10-K filed
14 Mar 202515.52%3.18
31 Mar 202518.63%5.03
15 Apr 202517.42%6.92results (8-K)
30 Apr 202517.75%3.64
15 May 202519.25%2.6710-Q filed, results (8-K)
30 May 202523.27%1.39
13 Jun 202527.13%2.15
30 Jun 202529.35%1.87
15 Jul 202529.12%3.35results (8-K)
31 Jul 202517.83%4.19results (8-K)
15 Aug 202515.44%3.7510-Q filed, results (8-K)
29 Aug 202516.91%4.84
15 Sep 202517.50%5.55
30 Sep 202521.23%1.49
15 Oct 202526.37%3.58results (8-K)
31 Oct 202514.05%1.91
14 Nov 202514.57%2.9810-Q filed
28 Nov 202515.84%5.33
15 Dec 202518.20%6.18
31 Dec 202518.20%6.85

See also: Semler Scientific, Inc.'s full history · most shorted US stocks of 2025 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.